logo
Products
Services
Resources
Selection Guides
About
APC Anti-human CD56 Antibody
B-A19
B-A19 is an anti-human monoclonal antibody that targets the CD56 antigen. CD56 (alternatively called NKH1 or NCAM-1) is a single-pass type i membrane protein that is expressed on the surface of cells like NK cells and T cells. CD56 has been associated with important biological processes like axon guidance, especially commissural neuron axon guidance. In addition, it plays a role in essential cellular pathways, for instance, the regulation of semaphorin-plexin signaling pathway and interferon-gamma-mediated signaling pathway. From a research standpoint, it is of biological interest due to its association with essential macromolecules/ligands such as Heparin sulfate. CD56 is a fairly uncommon antibody target, with a little more than 10000 publications in the last decade. Even still, CD56 has a variety of applications in research, often serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to APC (ex/em = 651/660 nm). It is compatible with the 642 nm laser and 664/20 nm bandpass filter (for example, as in the Luminex Guava easyCyte).
product image
product image
CatalogSize
Price
Quantity
105601C025 tests
Price
105601C1100 tests
Price
105601C2500 tests
Price
 
Antibody properties

Other namesLeu-19, NKH1, NCAM1
CloneB-A19
HostMouse
IsotypeIgG1
ReactivityHuman
Spectral properties

Correction factor (280 nm)0.195
Extinction coefficient (cm -1 M -1)
730000
Excitation (nm)651
Emission (nm)660
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on April 4, 2026